Anúncio
Anúncio

CLOV

CLOV logo

Clover Health Investments, Corp

2.59
USD
Patrocinado
+0.06
+2.37%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

2.62

+0.03
+0.97%

Relatórios de Lucros CLOV

Rácio de surpresa positiva

CLOV separação 14 de 19 últimas estimativas.

74%

Próximo Relatório

Data do Próximo Relatório
25 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$476.40M
/
-$0.10
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-4.08%
/
+100.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+41.38%
/
+150.00%

Clover Health Investments, Corp earnings per share and revenue

On 04 de nov. de 2025, CLOV reported earnings of -0.05 USD per share (EPS) for Q3 25, missing the estimate of -0.03 USD, resulting in a -63.40% surprise. Revenue reached 496.65 milhão, compared to an expected 480.51 milhão, with a 3.36% difference. The market reacted with a -15.77% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -0.10 USD, with revenue projected to reach 476.40 milhão USD, implying an aumentar of 100.00% EPS, and diminuir of -4.08% in Revenue from the last quarter.
FAQ
For Q3 2025, Clover Health Investments, Corp reported EPS of -$0.05, missing estimates by -63.4%, and revenue of $496.65M, 3.36% above expectations.
The stock price moved down -15.77%, changed from $3.52 before the earnings release to $2.96 the day after.
The next earning report is scheduled for 25 de fev. de 2026.
Based on 5 analistas, Clover Health Investments, Corp is expected to report EPS of -$0.10 and revenue of $476.40M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio